Express Scripts says costly new cholesterol drugs could wreak havoc
July 29, 2015 at 11:15 AM EDT
July 29 (Reuters) - Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent new cholesterol drugs called PCSK9 inhibitors could "wreak financial havoc" among its clients.